0000950170-24-014128.txt : 20240212
0000950170-24-014128.hdr.sgml : 20240212
20240212212403
ACCESSION NUMBER: 0000950170-24-014128
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Couling John D
CENTRAL INDEX KEY: 0001894052
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 24622315
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
ORGANIZATION NAME: 05 Real Estate & Construction
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4/A
1
ownership.xml
4/A
X0508
4/A
2024-02-08
2024-02-12
0001308547
Dolby Laboratories, Inc.
DLB
0001894052
Couling John D
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
false
true
false
false
SVP, Entertainment
true
Class A Common Stock
2024-02-08
4
M
false
50000
42.98
A
158519
D
Class A Common Stock
2024-02-08
4
S
false
50000
80
D
108519
D
Class A Common Stock
2024-02-09
4
M
false
12440
42.98
A
120959
D
Class A Common Stock
2024-02-09
4
M
false
21120
62.32
A
142079
D
Class A Common Stock
2024-02-09
4
S
false
33560
80.8074
D
108519
D
Employee Stock Option (Right to Buy)
42.98
2024-02-08
4
M
false
50000
0
D
2024-12-15
Class A Common Stock
50000
12440
D
Employee Stock Option (Right to Buy)
42.98
2024-02-09
4
M
false
12440
0
D
2024-12-15
Class A Common Stock
12440
0
D
Employee Stock Option (Right to Buy)
62.32
2024-02-09
4
M
false
21120
0
D
2024-12-15
Class A Common Stock
21120
0
D
The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023.
Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares.
/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling
2024-02-12